Company news

Starpharma Holdings Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

SPL docetaxel superior to Taxotere across multiple cancers

March 30, 2016

Dendrimers improve anticancer efficacy lung metastasis model

March 30, 2016

VivaGel study demonstrates reduced risk of recurrent BV

March 30, 2016

Starpharma Dendrimer-Docetaxel eliminates neutropenia

March 30, 2016

SPL Signs Priostar Agrochemical Partnership with Gowan

March 30, 2016

SPLs dendrimer a potential viral conjunctivitis treatment

March 30, 2016

Reduced neurotoxicity - SPLs dendrimer enhanced oxaliplatin

March 30, 2016

ARC grant for Starpharmas targeted drug delivery

March 30, 2016

VivaGel condom receives TGA device certification

March 30, 2016

VivaGel-coated condom approved for marketing in Japan

March 30, 2016

Starpharma Interim Report and Half-year Financial Results

March 30, 2016

Starpharma completes A$18 million placement, SPP to follow

March 30, 2016

Starpharma commences Dendrimer-Docetaxel clinical trial

March 30, 2016

Starpharma clinical trial programs accelerating

March 30, 2016

FDA Grants SPA Agreement for Phase 3 Recurrent BV Trial

March 30, 2016

Starpharma receives $4.2M R&D tax incentive refund

March 30, 2016

SPP Record Date Clarification

March 30, 2016

SPL: VivaGel condom approved for sale with launch imminent

March 30, 2016

DEP docetaxel - longer duration and increased exposure

March 30, 2016

Adama Licenses Starpharmas Priostar for Novel 2,4-D

March 16, 2016

Starpharma licences VivaGel BV to Aspen for ANZ

March 3, 2016

Targeted DEP shows sustained superior performance

February 11, 2016

VivaGel phase 3 study results

February 10, 2016

VivaGel Demonstrates Efficacy in Bacterial Vaginosis

February 10, 2016

VivaGel condom patent grant extends coverage

February 10, 2016

VivaGel Coated Condom Licence Agreement with Okamoto Japan

February 10, 2016

VivaGel BV Phase 3 trials - recruitment complete

February 10, 2016

Starpharma to recoup additional $2 million for overseas R&D

February 10, 2016

Starpharmas Priostar Glyphosate Patent Allowed in China

February 10, 2016

Starpharma signs MOU for VivaGel condom in China

February 10, 2016

Starpharma`s drug delivery program with Lilly advances

February 10, 2016

Starpharmas docetaxel demonstrates targeted tumour delivery

February 10, 2016

Starpharma receives $3.4M R&D tax incentive

February 10, 2016

Starpharma raises $1.9M under Share Purchase Plan

February 10, 2016

Starpharma Granted New Drug Delivery Patents

February 10, 2016

Starpharma expands Drug Delivery Program with AstraZeneca

February 10, 2016

Starpharma completes A$32 million placement, SPP to follow

February 10, 2016

Starpharma completes A$32 million placement

February 10, 2016

Starpharma announces Phase 2 BV study of VivaGel

February 10, 2016

Starpharma and Nufarm sign crop protection agreement

February 10, 2016

Starpharma advances agrochemical program

February 10, 2016

SPL to expand agricultural program through $250,000 funding

February 10, 2016

SPL: Marketing Clearance for VivaGel condom in New Zealand

February 10, 2016

SPL and Monash University collaboration receives ARC grant

February 10, 2016

Response to ASX Query

February 10, 2016

Response to ASX Price Query

February 10, 2016

New formulations show further improvement in crop protection

February 10, 2016

Japan VivaGel condom classification impacts launch timing

February 10, 2016

Full enrolment achieved for BV Phase 2 & first Phase 3 trial

February 10, 2016

EU Marketing Approval Granted for VivaGel BV

February 10, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 53 decks. Every deck is listed under its year.